COPD
Conditions
Keywords
COPD
Brief summary
This study evaluates the effect of a structured three-month pulmonary rehabilitation (PR) program, delivered both in-hospital and at home, on exercise capacity, respiratory symptoms, and functional status in stable COPD patients.
Detailed description
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality and morbidity worldwide, significantly reducing patients' physical activity and quality of life. This study investigates a tailored pulmonary rehabilitation program combining hospital-based and home-based components over 12 weeks. The hospital component includes patient education, nutritional support, structured exercise training for both upper and lower limbs, and smoking cessation strategies. The home program emphasizes continuity with daily walking, strength exercises, and lifestyle modifications. The program aims to improve exercise capacity, dyspnea scores, and quality of life. Assessments include the six-minute walk test (6MWT), CAT score, mMRC dyspnea scale, spirometry, arterial blood gas analysis, and the St George's Respiratory Questionnaire. Measurements are collected at baseline and after program completion to assess improvements.
Interventions
A tailored pulmonary rehabilitation program combining hospital-based and home-based components over 12 weeksParticipants undergo a 12-week structured PR program including both hospital-based sessions (education, structured exercise, nutrition counseling, smoking cessation) and home-based exercises (daily walking, strength training progression
Sponsors
Study design
Intervention model description
ince this is a quasi-experimental single-arm study, there is only one intervention group the Pulmonary Rehabilitation Group: Participants undergo a 12-week structured PR program including both hospital-based sessions (education, structured exercise, nutrition counseling, smoking cessation) and home-based exercises (daily walking, strength training progression).
Eligibility
Inclusion criteria
* Stable COPD patients diagnosed based on spirometry (post-bronchodilator FEV1/FVC \<70%) Age \> 40 years Moderate to severe COPD stage Able and willing to participate in rehabilitation program
Exclusion criteria
* Age \< 40 years Current acute COPD exacerbation at enrollment Significant comorbid conditions limiting participation (e.g., uncontrolled diabetes mellitus, uncontrolled hypertension, left-sided heart failure, renal failure, liver cell failure) Neuromuscular diseases, severe cognitive impairment, or psychiatric disturbance Pregnant patients Unwilling to participate in the rehabilitation program
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Six-Minute Walk Test (6MWT) | 12 weeks | Measures the distance (in meters) a patient can walk in six minutes as a marker of exercise capacity and functional endurance. |